The synergistic effect of rapamycin and IL-2 complexes has already been shown to ameliorate EAE, to promote the expansion of suppressive CD8+ Foxp3+ cells after BMT and to stabilize in vitro induced Tregs in a GVHD model [15,36,51]. Here, CD8A is linked to graft versus host disease.